Most Popular
-
6
[KH Explains] How should Korea adjust its trade defenses against Chinese EVs?
![[KH Explains] How should Korea adjust its trade defenses against Chinese EVs?](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/15/20240415050562_0.jpg&u=20240415144419)
-
7
BTS' Jungkook creates Instagram account for his dog
-
8
Korea braces for blows from Middle East conflict
-
9
Seoul says will cut power to porn festival planned on Han River
-
10
Korean won weakens amid heightened uncertainty
![[KH Explains] How should Korea adjust its trade defenses against Chinese EVs?](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/15/20240415050562_0.jpg&u=20240415144419)
S. Korean biotech firms eying phase 3 clinical trials of COVID-19 vaccines
By YonhapPublished : April 12, 2021 - 20:09
Five South Korean biotech companies are pushing for phase three clinical trials of COVID-19 vaccines in the second half of this year, the health ministry said Monday.
The government plans to inject about 68.7 billion won ($61 million) this year for the clinical trials of COVID-19 vaccines by SK Bioscience Co., EuBiologics Co., Cellid, Genexine and GeneOne Life Science, the ministry said.
The ministry made the announcement in a report to President Moon Jae-in.
Also Monday, the Ministry of Food and Drug Safety said it has received the application from South Korean biotech company GC Pharma for the approval of US biotech firm Moderna's COVID-19 vaccine.
In February, GC Pharma was selected as the company responsible for approval and distribution of Moderna's COVID-19 vaccine in South Korea.
In December, Moderna Chief Executive Stephane Bancel agreed to supply COVID-19 vaccine doses for 20 million people to South Korea during a videoconference with Moon. (Yonhap)
The government plans to inject about 68.7 billion won ($61 million) this year for the clinical trials of COVID-19 vaccines by SK Bioscience Co., EuBiologics Co., Cellid, Genexine and GeneOne Life Science, the ministry said.
The ministry made the announcement in a report to President Moon Jae-in.
Also Monday, the Ministry of Food and Drug Safety said it has received the application from South Korean biotech company GC Pharma for the approval of US biotech firm Moderna's COVID-19 vaccine.
In February, GC Pharma was selected as the company responsible for approval and distribution of Moderna's COVID-19 vaccine in South Korea.
In December, Moderna Chief Executive Stephane Bancel agreed to supply COVID-19 vaccine doses for 20 million people to South Korea during a videoconference with Moon. (Yonhap)
![[Today’s K-pop] Stray Kids to return soon: report](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/04/16/20240416050713_0.jpg&u=)